LIPELLA PHARMACEUTICALS INC. (LIPO)
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Address
400 N LEXINGTON ST
PITTSBURGH, PA 15208
Founded
2005
Number of Employees
7
Website
http://www.lipella.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)